The company is poised to begin a roadshow to pitch shares of its consumer-healthcare business, in a test for an IPO market that has been in the doldrums for the past year.
Source link
Tags: Bayer , BAYN.XE , C&E Industry News Filter , Content Types , corporate , Corporate Actions , Corporate Changes , Corporate Funding , corporate strategy , Corporate Strategy/Planning , Corporate/Industrial News , Earnings , Factiva Filters , Financial Performance , FR:SAN , Goldman Sachs Group , GS , Haleon , healthcare , Healthcare/Life Sciences , HLN.LN , industrial news , Initial Public Offerings , JNJ , Johnson & Johnson , JPM , JPMorgan Chase , kwexclusive , life sciences , MBLY , Mobileye Global Cl A , Over-the-counter Drugs , PG , Pharmaceuticals , planning , Procter & Gamble , Sales Figures , SAN.FR , Sanofi S.A. , Share Capital , Stock listings , SYND , UK:HLN , WSJ-PRO-WSJ.com , wsjfinance-ws , XE:BAYN
Continue Reading